- Home
- ARBEW vs MRK Comparison
ARBEW vs MRK Comparison
Compare ARBEW & MRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARBEW
- MRK
- Stock Information
- Founded
- ARBEW 2015
- MRK 2000
- Country
- ARBEW Israel
- MRK United States
- Employees
- ARBEW 144
- MRK N/A
- Industry
- ARBEW EDP Services
- MRK Biotechnology: Pharmaceutical Preparations
- Sector
- ARBEW Technology
- MRK Health Care
- Exchange
- ARBEW Nasdaq
- MRK Nasdaq
- Market Cap
- ARBEW N/A
- MRK 198.5B
- IPO Year
- ARBEW N/A
- MRK N/A
- Fundamental
- Price
- ARBEW $0.22
- MRK $83.30
- Analyst Decision
- ARBEW
- MRK Buy
- Analyst Count
- ARBEW 0
- MRK 15
- Target Price
- ARBEW N/A
- MRK $113.14
- AVG Volume (30 Days)
- ARBEW 32.4K
- MRK 18.0M
- Earning Date
- ARBEW 03-05-2025
- MRK 07-29-2025
- Dividend Yield
- ARBEW N/A
- MRK 3.89%
- EPS Growth
- ARBEW N/A
- MRK 667.14
- EPS
- ARBEW N/A
- MRK 6.88
- Revenue
- ARBEW $768,000.00
- MRK $63,922,000,000.00
- Revenue This Year
- ARBEW N/A
- MRK $2.42
- Revenue Next Year
- ARBEW N/A
- MRK $5.77
- P/E Ratio
- ARBEW N/A
- MRK $12.12
- Revenue Growth
- ARBEW N/A
- MRK 4.10
- 52 Week Low
- ARBEW $0.13
- MRK $73.31
- 52 Week High
- ARBEW $1.25
- MRK $129.93
- Technical
- Relative Strength Index (RSI)
- ARBEW N/A
- MRK 60.59
- Support Level
- ARBEW N/A
- MRK $80.15
- Resistance Level
- ARBEW N/A
- MRK $85.00
- Average True Range (ATR)
- ARBEW 0.00
- MRK 1.84
- MACD
- ARBEW 0.00
- MRK 0.37
- Stochastic Oscillator
- ARBEW 0.00
- MRK 75.22
About ARBEW Arbe Robotics Ltd. Warrant
Arbe Robotics Ltd is a provider of 4D Imaging Radar solutions enabling driver-assist systems while paving the way for fully autonomous driving. It is a research and development company in the field of chips for Advanced radar systems, which are mainly intended to be used as Advanced Driver Assistance Systems (ADAS) adapted for autonomous vehicles as well as for non-automotive uses. Its geographical segments include Sweden, China, Germany, Hong Kong, USA, Israel, Switzerland, Italy, and others.
About MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.